lorazepam

Generic: lorazepam

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lorazepam
Generic Name lorazepam
Labeler chartwell rx, llc
Dosage Form CONCENTRATE
Routes
ORAL
Active Ingredients

lorazepam 2 mg/mL

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-549
Product ID 62135-549_044c464b-af13-d50f-e063-6394a90ade25
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA079244
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2009-04-28

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135549
Hyphenated Format 62135-549

Supplemental Identifiers

RxCUI
311376
UPC
0362135549435
UNII
O26FZP769L
NUI
N0000175694 M0002356

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lorazepam (source: ndc)
Generic Name lorazepam (source: ndc)
Application Number ANDA079244 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 30 mL in 1 BOTTLE (62135-549-43)
source: ndc

Packages (1)

Ingredients (1)

lorazepam (2 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "044c464b-af13-d50f-e063-6394a90ade25", "openfda": {"nui": ["N0000175694", "M0002356"], "upc": ["0362135549435"], "unii": ["O26FZP769L"], "rxcui": ["311376"], "spl_set_id": ["e075c78d-f0c6-4380-b769-bb8833d23ba5"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 BOTTLE (62135-549-43)", "package_ndc": "62135-549-43", "marketing_start_date": "20230420"}], "brand_name": "Lorazepam", "product_id": "62135-549_044c464b-af13-d50f-e063-6394a90ade25", "dosage_form": "CONCENTRATE", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "62135-549", "dea_schedule": "CIV", "generic_name": "Lorazepam", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lorazepam", "active_ingredients": [{"name": "LORAZEPAM", "strength": "2 mg/mL"}], "application_number": "ANDA079244", "marketing_category": "ANDA", "marketing_start_date": "20090428", "listing_expiration_date": "20261231"}